KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 27, 2025 >>  ABB India 5239.9  [ 1.12% ]  ACC 1856.4  [ 0.35% ]  Ambuja Cements 559.95  [ 0.81% ]  Asian Paints Ltd. 2518  [ 0.60% ]  Axis Bank Ltd. 1254.15  [ 0.97% ]  Bajaj Auto 9096.4  [ 0.15% ]  Bank of Baroda 274  [ 2.87% ]  Bharti Airtel 2081.05  [ 2.56% ]  Bharat Heavy Ele 235.3  [ 1.75% ]  Bharat Petroleum 343  [ 3.92% ]  Britannia Ind. 5928  [ -2.02% ]  Cipla 1585  [ 0.08% ]  Coal India 396.7  [ 0.66% ]  Colgate Palm 2217.45  [ -0.91% ]  Dabur India 505.4  [ -0.60% ]  DLF Ltd. 778.55  [ 0.69% ]  Dr. Reddy's Labs 1284.6  [ 0.05% ]  GAIL (India) 180.3  [ -0.44% ]  Grasim Inds. 2925  [ 3.05% ]  HCL Technologies 1535  [ 0.74% ]  HDFC Bank 1002.9  [ 0.82% ]  Hero MotoCorp 5648.5  [ 1.99% ]  Hindustan Unilever L 2511.9  [ -0.22% ]  Hindalco Indus. 840.8  [ 2.02% ]  ICICI Bank 1377.7  [ 0.16% ]  Indian Hotels Co 746.5  [ 1.40% ]  IndusInd Bank 770.65  [ 2.02% ]  Infosys L 1504.8  [ -1.35% ]  ITC Ltd. 420.35  [ 0.78% ]  Jindal Steel 1030.1  [ 2.23% ]  Kotak Mahindra Bank 2148.85  [ -1.74% ]  L&T 3924.7  [ 0.52% ]  Lupin Ltd. 1922.45  [ -0.46% ]  Mahi. & Mahi 3611.35  [ -0.37% ]  Maruti Suzuki India 16384.3  [ 0.74% ]  MTNL 42.21  [ 0.50% ]  Nestle India 1282.7  [ 0.10% ]  NIIT Ltd. 106.1  [ -0.70% ]  NMDC Ltd. 74.39  [ 0.24% ]  NTPC 342.05  [ 0.77% ]  ONGC 253.25  [ -0.63% ]  Punj. NationlBak 119.8  [ 2.48% ]  Power Grid Corpo 290.9  [ 0.81% ]  Reliance Inds. 1484  [ 2.24% ]  SBI 923.25  [ 2.08% ]  Vedanta 505.05  [ 1.89% ]  Shipping Corpn. 271.7  [ -0.89% ]  Sun Pharma. 1694.1  [ -0.32% ]  Tata Chemicals 893.75  [ -0.73% ]  Tata Consumer Produc 1170  [ 1.34% ]  Tata Motors Passenge 410.1  [ 1.64% ]  Tata Steel 176.6  [ 1.20% ]  Tata Power Co. 400.25  [ 0.72% ]  Tata Consultancy 3084.55  [ 0.72% ]  Tech Mahindra 1463  [ 0.68% ]  UltraTech Cement 12009.05  [ 0.82% ]  United Spirits 1352  [ -0.33% ]  Wipro 243.9  [ 0.39% ]  Zee Entertainment En 103.1  [ -1.62% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

VENMAX DRUGS & PHARMACEUTICALS LTD.

27 October 2025 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE154G01022 BSE Code / NSE Code 531015 / VENMAX Book Value (Rs.) -1.26 Face Value 10.00
Bookclosure 21/09/2024 52Week High 37 EPS 0.00 P/E 0.00
Market Cap. 14.80 Cr. 52Week Low 6 P/BV / Div Yield (%) -22.42 / 0.00 Market Lot 1.00
Security Type Other

History of Company

The company history sections lists out major chronological events that happened to the company.
Yenkey Drugs and Pharmaceuticals Ltd., was originally incorporated on 28th September, 1988 in the name of Yenkey Medico Drugs Private Limited. The Company has been converted into a public limited company on 3rd Feb'95 in terms of a special resolution passed on 23.01.95 under Section 31(1)/44 of the Companies Act, 1956. Accordingly the Company has obtained a fresh Certificate of Incorporation consequent on the conversion from the Registrar of Companies, Andhra Pradesh vide ref. no. 01-09102 dated 3rd February, 1995.

The Company is producing bulk drug intermediates as detailed above and marketing in the domestic markets. The total turnover of the Company is Rs. 89.70 lacs for the year ended March 1994. Now the Company proposes to expand the existing capacity of dye and drug intermediate viz; ECA and diversifying into manufacturing of high value chemicals and bulk drugs viz; Sodium Azide and Vitamin B2 Phosphate.

The Company is also proposing to set up a R & D Unit for maintaining high quality control standards of foreign buyers.

2009

-Company has changed its name from Yenkey Drugs and Pharmaceuticals Ltd. to Venmax Drugs & Pharmaceuticals Ltd.

--Registered Office of the Company has been shifted from Plot No. 1-B12, 2nd floor, S.V.Co-operative Industrial Estate, Balanagar, Hyderabad - 500 037 to 8-3-319/3, Behind Sarathi Studio, Yellareddyguda, Hyderabad - 500 073. 2013 -Venmax Drugs and Pharmaceuticals Ltd has informed that Registered office has been shifted from "Plot No-35,Shivbagh Colony, Ameerpet, Hyderabad - 16" TO "H.NO 6-3-349/35, Flat No-21B, Dwaraka Avenue, DwarakaPuri Colony, Punjagutta, Hyderabad - 32".

2023 -Acquired Brownfield Hotel in Varanasi Uttar Pradesh and Aloft Bengaluru Whitefield Hotel in Karnataka.

2024 - Launched Raaya by atmosphere in Maldives. -Completed the Acquistion transaction pursuant to which our company directly/ indlrectly acquired - Aloft ORR Bengaluru, Anantara Maldives and Conrad Maldives.